Polymorphous ventricular tachycardia in acute myocardial infarction.

Abstract

Polymorphous ventricular tachycardia (VT) is thought to be uncommon in acute coronary heart disease, but its prevalence has not been determined. Seven hundred seventy-one consecutive patients admitted with acute myocardial infarction (MI) were reviewed for the occurrence of this arrhythmia. Nine patients (1.2%) had polymorphous VT. No patient had any of the predisposing factors previously associated with polymorphous VT. The arrhythmia was resistant to multiple drugs, and repeated cardioversion was effective in only 3 patients. Overdrive pacing was ineffective in the 3 patients in whom it was attempted. Verapamil was effective in 3 of 4 patients in whom it was tried. Six patients with polymorphous VT died during hospitalization; the remaining 3 died within 6 months of discharge. It is concluded that, when compared with regular VT, polymorphous VT in MI carries a poor prognosis. When the arrhythmia occurs in the context of acute ischemia, it appears to be more difficult to treat compared with its occurrence due to other predisposing factors. Verapamil, not usually indicated for ventricular arrhythmias, should be tested in a therapeutic trial.

• Authors: E Grenadier, G Alpan, N Maor, S Keidar, C Binenboim, T Margulies, A Palant
• Journal: The American journal of cardiology (Am J Cardiol) Vol. 53 Issue 9 Pg. 1280-3 (May 01 1984) ISSN: 0002-9149 [Print] United States
• PMID: 6711428 (Publication Type: Journal Article)

Chemical References

• Verapamil

Topics

• Aged
• Cardiac Pacing, Artificial
• Electric Countershock
• Electrocardiography
• Female
• Humans
• Male
• Middle Aged
• Myocardial Infarction (complications)
• Prognosis
• Tachycardia (epidemiology, etiology, therapy)
• Verapamil (therapeutic use)